Skip to content

Understanding What are the grades of neovascularization?

4 min read

Over 200,000 Americans are diagnosed with age-related macular degeneration (AMD) each year, a condition often involving abnormal blood vessel growth. Understanding what are the grades of neovascularization is a critical step in assessing the severity and guiding the treatment of various medical conditions, primarily those affecting the eye.

Quick Summary

Neovascularization is not graded with a single universal system but rather through specialized classifications tailored to the specific body part affected, such as the cornea, retina, or choroid. The grading systems categorize the severity based on factors like vessel size, location, and maturity, informing the appropriate treatment plan.

Key Points

  • Location-Dependent Grading: Neovascularization is graded according to the specific tissue involved, with different systems for the cornea, choroid, and retina.

  • Corneal Severity: Corneal neovascularization (CoNV) is graded based on the extent of vascular invasion into the clear cornea from the limbus.

  • Choroidal Classification: Choroidal neovascularization (CNV) is classified anatomically into Types 1, 2, and 3, depending on its position relative to the retinal pigment epithelium.

  • Retinal Staging: In diabetic retinopathy, retinal neovascularization is staged based on whether new vessels are on the optic disc (NVD) or elsewhere (NVE).

  • Diagnostic Importance: Accurate grading is essential for appropriate diagnosis, effective treatment planning, and predicting long-term visual prognosis.

  • Advanced Imaging: Modern techniques like OCT and fluorescein angiography are crucial for precise grading and understanding the extent of neovascular damage.

In This Article

The Diverse Nature of Neovascularization Grading

Neovascularization is the formation of new, often fragile and leaky, blood vessels. The specific system used to grade its severity is not universal and depends heavily on the location within the body and the underlying disease. In ophthalmic practice, different grading scales apply to the cornea, retina, and choroid, as each tissue has a unique vascular anatomy and disease process.

Grading Corneal Neovascularization

Corneal neovascularization (CoNV) is a significant risk factor for corneal graft rejection and can be caused by various factors, including infection, inflammation, or trauma. Several grading systems exist, but many rely on the extent and characteristics of the invading vessels.

A simplified four-grade scale for CoNV is often used:

  • Grade 1: Peripheral vascularization extends less than 2mm into the clear cornea from the limbus.
  • Grade 2: The peripheral vascularization extends more than 2mm but does not reach the central cornea.
  • Grade 3: The neovascularization involves the central cornea.
  • Grade 4: The most severe grade, with extensive vascularization of the entire cornea, often with associated fibrosis.

Alternative classifications focus on vessel maturity:

  • Active young vessels: Bright red, fine capillary networks showing progression and leakage.
  • Active old vessels: Less bright, not actively progressing.
  • Mature vessels: Larger, less branched vessels in scar tissue.
  • Regressed (ghost) vessels: Fine white lines indicating prior vessel presence without blood flow.

Classifying Choroidal Neovascularization

Choroidal neovascularization (CNV) is a hallmark of the 'wet' form of age-related macular degeneration (AMD). The classification is primarily anatomical, describing where the new blood vessels form relative to the retinal pigment epithelium (RPE) and Bruch's membrane.

The main types of CNV include:

  1. Type 1 (Occult CNV): The neovascular membrane is located under the RPE. It demonstrates occult or ill-defined leakage on fluorescein angiography. Polypoidal choroidal vasculopathy (PCV) is a subtype of Type 1 CNV.
  2. Type 2 (Classic CNV): The neovascularization breaks through the RPE and is located above it in the subretinal space. It appears as a well-defined area of leakage on angiography.
  3. Mixed Type: A combination of Type 1 and Type 2 CNV.
  4. Type 3 (Retinal Angiomatous Proliferation - RAP): This form involves neovascularization that begins within the neurosensory retina and then grows posteriorly toward the choroid.

Staging Retinal Neovascularization

In conditions like diabetic retinopathy, neovascularization is staged based on the location and severity of the new vessel growth within the retina. The system for proliferative diabetic retinopathy (PDR) distinguishes neovascularization on the optic disc (NVD) from neovascularization elsewhere (NVE).

The stages of PDR are often summarized as:

  • Moderate NPDR: Precursor stage with microaneurysms and hemorrhages.
  • Severe NPDR: Increased severity, often defined by the '4-2-1' rule (hemorrhages in four quadrants, venous beading in two, and intraretinal microvascular abnormalities in one).
  • PDR: The presence of new vessels (NVD or NVE). The severity is further categorized based on the extent and location of the new vessels, with NVD being a higher risk factor for severe vision loss.

Comparison of Grading Systems

Feature Corneal Neovascularization Choroidal Neovascularization Retinal Neovascularization
Basis for Grading Extent of vascular invasion from the limbus and vessel maturity. Anatomic location relative to the RPE and Bruch's membrane. Location (optic disc vs. elsewhere) and extent of new vessel growth.
Key Terms Peripheral vs. Central, Active, Mature, Ghost Vessels. Occult (Type 1), Classic (Type 2), Mixed, RAP (Type 3). NVD (at disc), NVE (elsewhere), High-risk PDR.
Imaging Method Slit-lamp exam, photography, fluorescein angiography. Fluorescein angiography, OCT, OCT angiography. Fundus photography, fluorescein angiography.
Clinical Focus Managing inflammation, preventing graft rejection, improving transparency. Treating exudation, preventing macular damage. Preventing vitreous hemorrhage and tractional retinal detachment.

The Diagnostic Process

Accurate grading requires a comprehensive ophthalmic examination. This process often involves several key steps:

  • Clinical Examination: A slit-lamp biomicroscopy allows direct visualization of the neovascularization.
  • Fluorescein Angiography (FA): A dye is injected into the bloodstream, and photographs are taken as it circulates through the eye's vessels. This highlights abnormal vessels and associated leakage.
  • Optical Coherence Tomography (OCT): This imaging technique provides high-resolution cross-sectional images, allowing specialists to precisely localize the new vessels and assess associated fluid.
  • OCT Angiography (OCTA): A non-invasive method that can image the vascular flow, improving the detection and classification of neovascular membranes.

Treatment Implications

The grade or type of neovascularization is a critical factor in determining the appropriate treatment. For example, in wet AMD, the type of CNV and the extent of fluid buildup directly influence the frequency and dosage of anti-VEGF injections. In CoNV, the severity might dictate whether treatment involves anti-inflammatory drops, laser therapy, or more invasive surgical procedures. In PDR, the presence of high-risk characteristics, including neovascularization, guides the decision to perform panretinal photocoagulation (PRP) or anti-VEGF therapy to prevent further progression and vision loss.

Conclusion

Neovascularization grading is not a one-size-fits-all process but a specialized approach that requires understanding the specific anatomical location and disease context. From the extent of corneal invasion to the anatomical position of choroidal membranes or the presence of new vessels in diabetic retinopathy, precise grading provides clinicians with the information needed for accurate diagnosis and effective management. Advances in imaging technologies, such as OCTA, continue to refine these grading systems, enabling more precise evaluation and targeted treatment strategies.

For more detailed information on ophthalmological diseases, you can consult resources like the EyeWiki.

Frequently Asked Questions

Neovascularization manifests differently depending on the tissue and underlying disease. A single system would not adequately capture the unique characteristics of, for example, new vessels in the cornea versus those in the retina.

The main difference is anatomical location. Type 1 (occult) lies beneath the retinal pigment epithelium (RPE), whereas Type 2 (classic) has broken through the RPE and is located in the subretinal space.

It is typically evaluated using a slit-lamp examination and photography. Grading involves assessing the extent of vascular invasion into the cornea, often measured in millimeters or based on how far it has progressed toward the central vision.

Ghost vessels are the remnants of regressed neovascularization. They appear as fine white lines in the cornea, indicating where blood vessels previously existed but have since closed off.

Yes. In proliferative diabetic retinopathy (PDR), neovascularization is a key feature. Its location and extent (e.g., neovascularization of the disc vs. elsewhere) are important grading criteria that determine treatment urgency.

Angiography, such as fluorescein angiography, helps visualize blood flow and identify areas of leakage from the new, abnormal vessels. This information is critical for classifying CNV and confirming active disease.

Absolutely. The grade and type of neovascularization are crucial for guiding treatment. For instance, the treatment protocol for wet AMD often depends on the specific CNV subtype (Type 1, 2, or 3), and the maturity of vessels can influence the response to therapy.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.